Page 4 - ஜய்துச் ஆரோக்கியம் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜய்துச் ஆரோக்கியம் வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜய்துச் ஆரோக்கியம் வரையறுக்கப்பட்டவை Today - Breaking & Trending Today

Government continuously working to improve ease of doing business in pharma sector: Minister

Government continuously working to improve ease of doing business in pharma sector: Minister
SECTIONS
Last Updated: Feb 25, 2021, 03:42 PM IST
Share
Synopsis
Under the leadership of Prime Minister Narendra Modi, the government continues to strive to improve the ease of doing business in the country. Vigorous effort is on to reduce the regulatory compliance burden on the (pharma) industry, Gowda said.
Union minister D V Sadanand Gowda. (File photo)
The government is continuously working to reduce regulatory compliance burden on the pharma industry in a bid to improve ease of doing business in the country, Union Minister for Chemicals & Fertilisers D V Sadananda Gowda said on Thursday. Addressing the inaugural session of The India Pharma 2021 & India Medical Device 2021 event here, the minister also emphasised that the domestic pharma industry has the capability to achieve the target of USD 130 billion turnover by 2030. ....

Ayushman Bharat Yojana , Narendra Modi , Pankajr Patel , Dv Sadananda Gowda , Aatmanirbhar Bharat , Mansukh Mandaviya , Department Of Pharmaceuticals , Union Minister , Fertilisersdv Sadananda Gowda , India Pharma , Medical Device , Prime Minister Narendra Modi , Fertilisers Mansukh Mandaviya , Chairman Pankajr Patel , Pradhan Mantri Bhartiya Janaushadhi , Pollution Control Board , ஆயுஷ்மான் பாரத் யோஜனா , நரேந்திர மோடி , ட்வ் சதானந்த கவுடா , மன்சுக் மண்டவியா , துறை ஆஃப் மருந்துகள் , தொழிற்சங்கம் அமைச்சர் , இந்தியா பார்மா , மருத்துவ சாதனம் , ப்ரைம் அமைச்சர் நரேந்திர மோடி , உரங்கள் மன்சுக் மண்டவியா ,

Zydus to expand vaccine capacity

Zydus to expand vaccine capacity
Zydus Cadila seeks to produce 150 million doses of its covid vaccine ZyCoV-D annually
(MINT PRINT)Premium
The company has invested ₹250-350 crore so far on trials of the vaccine and its manufacturing
Zydus Cadila expects to submit to the drug regulator its safety and efficacy data for the vaccine in either April or June
Share Via
Read Full Story
Zydus Cadila Ltd will expand capacity of its covid-19 vaccine ZyCoV-D to produce 150 million doses a year and hire contract manufacturers to make an additional 50 to 70 million doses, a company spokesperson said.
“We have been investing a large amount of our capacities in building the vaccine, so we will now be able to produce 150 million doses of the vaccine annually, the spokesperson said, adding that the vaccine will be produced at its Zydus Biotech Park plant in Ahmedabad. ....

United Kingdom , South Africa , Zydus Cadila , Narendra Modi , Uddhav Thackeray , Serum Institute Of India Covishield , Bharat Biotech International , University Of Oxford , World Health Organization , India Inc , Astrazeneca Plc , Read India Inc , Zydus Biotech Park , Minister Narendra Modi , Serum Institute , Drugs Controller General , Join Mint , Zydus Covid 19 Vaccine , Zydus Covid Vaccine , Zydus Vaccine Trial , Zydus Zycov D , Zycovd Covid Vaccine , ஒன்றுபட்டது கிஂக்டம் , ஜய்துச் காடிலா , நரேந்திர மோடி , உத்தவ் தாக்கரே ,

Row over Zydus vaccine trials as Noida seals illegal lab | Noida News

A banner outside the lab that was sealed says it’s a free corona vaccine camp, courtesy ‘Nari Raksha Dal’
GREATER NOIDA: Phase III trials of Indian pharma major Zydus Cadila’s Covid-19 vaccine at a Ghaziabad hospital ran into controversy on Tuesday when an unrecognised private laboratory at Dadri in Greater Noida that had an understanding with the hospital was found to be administering the shots.
Five people present in the lab, all employees of the hospital, according to health department officials, were arrested. Noida’s chief medical officer said the laboratory was not authorised to administer any vaccine. Officials said 19 people had taken the shots at the lab, all on Tuesday. ....

Uttar Pradesh , Noida Vishal Pandey , Manoj Singh , A Zydus Cadila , Zydus Cadila Covid , Health Department , Zydus Cadila , Greater Noida , Gopal Pathology , Deepak Ohri , Vishal Pandey , Drugs Controller General , Noida News , Noida Latest News , Noida News Live , Noida News Today , Today News Noida , Zydus Vaccine Trials , Vaccine Trials , Seals Illegal Lab , Row Over Zydus Vaccine , Noida Seals Illegal Lab , உத்தர் பிரதேஷ் , நொய்டா விஷால் பாண்டே , மனோஜ் சிங் , ஆரோக்கியம் துறை ,

Cadila Healthcare Q3 results: Net profit up 41% to Rs 527 crore

Cadila Healthcare Q3 results: Net profit up 41% to Rs 527 crore
SECTIONS
Last Updated: Feb 05, 2021, 04:02 PM IST
Share
Synopsis
The company had posted a net profit of Rs 373.9 crore for the corresponding period of the previous fiscal, Cadila Healthcare said in a filing to BSE.
Consolidated revenue of the company stood at Rs 3,795.6 crore for the quarter under consideration. It was Rs 3,638.1 crore for the same period a year ago, it added.
Related
NSE
Drug firm
Cadila Healthcare on Friday reported a 41 per cent rise in its consolidated net profit to Rs 527.2 crore for the quarter ended December 2020 on account of robust sales in all segments. ....

United States , Dapaglyn Dapagliflozin , Apurvas Diwanji , Zydus Group , Drug Administration , Cadila Healthcare , United States Food , Pegylated Interferon , Chronic Obstructive Pulmonary Disorder , Independent Director , India Geography , United States Food And Drug Administration , ஒன்றுபட்டது மாநிலங்களில் , அபுர்வஸ் திவான்ஜி , ஜய்துச் குழு , காடிலா சுகாதாரம் , ஒன்றுபட்டது மாநிலங்களில் உணவு , நாள்பட்ட தடைசெய்யும் நுரையீரல் கோளாறு , சுயாதீனமான இயக்குனர் , இந்தியா நிலவியல் ,

Zydus Cadila gets USFDA nod for thyroid drug

Zydus Cadila gets USFDA nod for thyroid drug
SECTIONS
Last Updated: Jan 23, 2021, 12:07 PM IST
Share
Synopsis
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory filing.
iStock
Representative Image
New Delhi: Drug firm Zydus Cadila has received final approval from the US health regulator to market Liothyronine Sodium tablets that are used to treat underactive thyroid. Liothyronine is a man-made form of thyroid hormone which is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally made by the thyroid gland. ....

New Delhi , Zydus Cadila , Drug Administration , Liothyronine Sodium , Cadila Healthcare , Us Food And Drug Administration , Thyroid Hormone , Underactive Thyroid , புதியது டெல்ஹி , ஜய்துச் காடிலா , காடிலா சுகாதாரம் , தைராய்டு ஹார்மோன் ,